COVISHIELD

The National Agency for Food and Drug Administration and Control (NAFDAC) says it has not approved any drug or vaccine for the treatment of COVID-19.

NAFDAC advises Nigerians to ensure vaccines have original AstraZeneca labels

March 21, 2021

Namibia plans to go ahead with the roll-out of the AstraZeneca vaccine even after South Africa stalled its use because trials showed it’s less effective against mild infection of a Covid-19 strain dominant in the region.

No link between AstraZeneca vaccines, blood clot in Ghana yet – agency

March 16, 2021

The Director-General of National Agency for Food and Drug Administration and Control (NAFDAC), Mojisola Adeyeye has criticised the overdependence on importation in Nigeria.

Official: Why NAFDAC approved Oxford-AstraZeneca coronavirus vaccine

February 18, 2021

The Minister of Health, Dr. Osagie Ehanire, has said that peace and harmony have returned to the National Health Insurance Scheme, NHIS.

Nigeria evaluating four coronavirus vaccines – minister

February 16, 2021

4. The NCDC and partners, with leadership from the Federal Ministry of Health and Presidential Task Force (PTF) on COVID-19 is putting in place measures to strengthen the public health response to the pandemic.

Coronavirus: Nigerian government to vaccinate 109 million residents in two years

February 15, 2021

Myanmar resumed the vaccination programme against COVID-19 across the country on Friday, according to an announcement from the Health and Sports Ministry.

Myanmar resumes vaccination programme against coronavirus

February 5, 2021

The African Union has secured an additional 400 million doses of Covid-19 vaccines for its members, the Africa Centres for Disease Control and Prevention (Africa CDC) said on Thursday.

African Union secures additional 400 million coronavirus vaccine doses

January 28, 2021

India probes deadly blaze at coronavirus vaccine production site

January 23, 2021

India’s drug regulator, the Central Drugs Standard Control Organisation (CDSCO), had recently granted authorisation for the local production and emergency use of two vaccines developed by AstraZeneca with Oxford University (Covishield) and local firm Bharat Biotech (Covaxin).

India to ‘commence exporting coronavirus vaccine in weeks’

January 5, 2021

A statement from the Press and Public Affairs Officer, British Deputy High Commission, Lagos said the UK regulator has accepted the recommendation of the Commission on Human Medicines and authorised the Oxford University/AstraZeneca Covid-19 vaccine, following months of rigorous clinical trials involving tens of thousands of people and an extensive analysis of the vaccine’s safety, quality and effectiveness by the Medicines and Healthcare products Regulatory Agency (MHRA).

India approves AstraZeneca, local coronavirus vaccines

January 2, 2021

India approves AstraZeneca’s coronavirus vaccine

January 2, 2021

India on Saturday staged nationwide drills to start one of the world’s biggest coronavirus vaccination programmes as the drug regulator prepared to approve the first vaccine.

India holds vaccine drills ahead of mass inoculation drive

January 2, 2021

On Monday, Indian biotechnology company Bharat Biotech asked the Drugs Controller General of India for emergency use authorisation of its coronavirus vaccine Covaxin.

India develops app to track coronavirus vaccination

December 9, 2020

Adar Poonawalla, CEO of the Serum Institute of India, said the vaccine will “save countless lives” [Francis Mascarenhas-Reuters]

India’s Serum Institute seeks approval for COVID-19 vaccine

December 7, 2020